2. Overall and subgroup analysis of medical and non-medical expenditure for liver cancer diagnosis and treatment per case.
| Variables | Medical expenditure (CNY) | Non-medical
expenditure (CNY) |
Overall expenditure | ||
| Value (CNY) | Statistics* | P* | |||
| *, Two-sample Student test after logarithm transition for two groups comparative analysis, analysis of variance (ANOVA) test after logarithm transition for more than two groups comparative analysis. | |||||
| Total | 48,612 | 4,608 | 53,220 | − | − |
| Hospital type | |||||
| General | 40,570 | 3,773 | 44,343 | −5.56 | <0.001 |
| Specialized | 51,211 | 4,878 | 56,089 | ||
| Age at diagnosis (year) | |||||
| <45 | 52,605 | 4,880 | 57,485 | 2.65 | 0.047 |
| 45−54 | 50,595 | 4,779 | 55,374 | ||
| 55−64 | 46,474 | 4,745 | 51,219 | ||
| ≥65 | 46,318 | 3,967 | 50,285 | ||
| Gender | |||||
| Male | 49,294 | 4,630 | 53,924 | 1.28 | 0.201 |
| Female | 46,018 | 4,525 | 50,543 | ||
| Education | |||||
| Primary school or below | 43,080 | 3,597 | 46,677 | 23.21 | <0.001 |
| Junior high school | 45,280 | 3,994 | 49,274 | ||
| Senior high school | 52,873 | 5,381 | 58,254 | ||
| Undergraduate or over | 67,373 | 8,073 | 75,446 | ||
| Occupation | |||||
| Farmer | 42,643 | 3,702 | 46,345 | 9.55 | <0.001 |
| Enterprise or company employee/worker | 49,453 | 4,508 | 53,961 | ||
| Self-employed or unemployed | 48,402 | 4,738 | 53,140 | ||
| Retiree | 56,053 | 7,255 | 63,308 | ||
| Staff in institution/civil servant | 67,797 | 5,794 | 73,591 | ||
| Other | 45,513 | 4,696 | 50,209 | ||
| Health-care insurance type | |||||
| Urban employees basic medical insurance | 53,250 | 5,286 | 58,536 | 8.49 | <0.001 |
| Urban residents basic medical insurance | 51,452 | 4,798 | 56,250 | ||
| New rural cooperative medical scheme | 43,515 | 3,933 | 47,448 | ||
| Commercial insurance | 20,876 | 1,345 | 22,221 | ||
| Self-financed | 44,158 | 4,345 | 48,503 | ||
| Other | 55,604 | 5,513 | 61,117 | ||
| Previous year household income | |||||
| <20,000 | 40,684 | 4,212 | 44,896 | 8.57 | <0.001 |
| 20,000−39,999 | 45,170 | 4,390 | 49,560 | ||
| 40,000−69,999 | 50,461 | 4,814 | 55,275 | ||
| ≥70,000 | 53,402 | 4,720 | 58,122 | ||
| Clinical stage | |||||
| I | 48,644 | 4,173 | 52,817 | 1.56 | 0.198 |
| II | 46,616 | 4,261 | 50,877 | ||
| III | 46,319 | 4,359 | 50,678 | ||
| IV | 49,063 | 5,026 | 54,089 | ||
| Therapeutic regimen | |||||
| Surgery | 57,641 | 4,970 | 62,611 | 19.82 | <0.001 |
| Chemotherapy | 45,773 | 4,652 | 50,425 | ||
| Surgery and postoperative chemotherapy | 55,042 | 5,070 | 60,112 | ||
| Symptomatic treatment | 44,837 | 4,644 | 49,481 | ||
| Concurrent chemoradiotherapy | 50,892 | 4,524 | 55,416 | ||
| Radiotherapy | 56,251 | 4,943 | 61,194 | ||
| Neoadjuvant chemoradiotherapy and surgery | 42,449 | 4,747 | 47,196 | ||
| Pathological type | |||||
| Hepatocellular carcinoma | 50,937 | 4,592 | 55,529 | 0.96 | 0.338 |
| Other | 48,143 | 4,213 | 52,356 | ||